Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930056 · ClinicalTrials.gov registry record · NA
C-Brace II Spinal Cord Injury
A NA study of Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03930056: Active NA study of Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab.
NCT03930056 is a NA study of Spinal Cord Injury that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 30 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03930056, a NA study of Spinal Cord Injury, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, repeated measures comparative design study to compare use of a micro-processor controlled knee-ankle-foot orthosis vs. traditional care knee-ankle-foot-orthosis (KAFO) models following discharge from inpatient rehabilitation.
Primary Outcome
The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. This test will be administered while wearing a mask to measure oxygen consumption.
Conditions Studied
Interventions
- DEVICE C-Brace II
- DEVICE Traditional Care KAFO intervention
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2026-11 |
| Phase | NA |
What the registry record for NCT03930056 still lists
NCT03930056 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which C-Brace II is the first listed.
NCT03930056 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03930056 about?
NCT03930056 is a clinical study titled "C-Brace II Spinal Cord Injury". A randomized, repeated measures comparative design study to compare use of a micro-processor controlled knee-ankle-foot orthosis vs. traditional care knee-ankle-foot-orthosis (KAFO) models following discharge from inpatient rehabilitation.
What is the current status of trial NCT03930056?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2019-04-16. Estimated completion is 2026-11.
What conditions does trial NCT03930056 study?
This clinical trial studies the following conditions: Spinal Cord Injury.
What interventions are being tested in trial NCT03930056?
The interventions under investigation include: C-Brace II (DEVICE), Traditional Care KAFO intervention (DEVICE).
Who is sponsoring clinical trial NCT03930056?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03930056 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03930056's enrollment target sits among peer trials
30 46th of 99 higher than 52 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI